Overview
Daisuke Ishida practices practicing medicine in Osaka, Japan.
His clinical expertise encompasses Mediastinal Tumor, Empyema, Squamous Cell Lung Carcinoma, and Lung Cancer.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Daisuke Ishida
Is Daisuke Ishida a top-rated expert for Mediastinal Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Daisuke Ishida is classified as an Experienced expert for Mediastinal Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Daisuke Ishida participate in research or clinical trials?
Yes. Daisuke Ishida has published 9 articles and abstracts on conditions like Mediastinal Tumor. You can view a list of Daisuke Ishida's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EmpyemaMr. Ishida isExperienced. Learn about Empyema.
- Lung CancerMr. Ishida isExperienced. Learn about Lung Cancer.
- Mediastinal TumorMr. Ishida isExperienced. Learn about Mediastinal Tumor.
- Squamous Cell Lung CarcinomaMr. Ishida isExperienced. Learn about Squamous Cell Lung Carcinoma.